Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-12 Sale |
2022-08-16 5:36 pm |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
57,743 | $38.31 | $2,211,978 | 10,000 (Direct) |
View |
| 2022-03-04 Sale |
2022-03-08 7:32 pm |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
51,168 | $30.63 | $1,567,394 | 10,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-11 Option Award |
2024-03-12 6:37 pm |
N/A 2034-03-10 |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
65,000 | $0 | 65,000 (Direct) |
View |
| 2023-03-10 Option Award |
2023-03-14 4:27 pm |
N/A 2033-03-09 |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-08-12 Exercise |
2022-08-16 5:36 pm |
N/A 2027-10-22 |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
65,000 | $0 | 10,000 (Direct) |
View |
| 2022-08-12 Tax Withholding |
2022-08-16 5:36 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
7,257 | $38.02 | 10,000 (Direct) |
View |
| 2022-08-12 Exercise |
2022-08-16 5:36 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
20,000 | $3.1 | 10,000 (Direct) |
View |
| 2022-08-12 Exercise |
2022-08-16 5:36 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
45,000 | $4.75 | 10,000 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 4:10 pm |
N/A 2032-03-09 |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
65,000 | $0 | 65,000 (Direct) |
View |
| 2022-03-07 Exercise |
2022-03-08 7:32 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
40,000 | $6.76 | 10,000 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 7:32 pm |
N/A 2027-03-12 |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
67,500 | $0 | 10,000 (Direct) |
View |
| 2022-03-07 Tax Withholding |
2022-03-08 7:32 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
9,647 | $30.23 | 10,000 (Direct) |
View |
| 2022-03-04 Exercise |
2022-03-08 7:32 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
27,500 | $8.4 | 10,000 (Direct) |
View |
| 2022-03-04 Tax Withholding |
2022-03-08 7:32 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
6,685 | $31.42 | 10,000 (Direct) |
View |
| 2021-03-12 Option Award |
2021-03-15 4:35 pm |
N/A 2031-03-11 |
Xenon Pharmaceuticals Inc. | XENE | EMPFIELD JAMES R. EVP, Drug Discovery |
65,000 | $0 | 65,000 (Direct) |
View |